Effets des inhibiteurs calciques sur la progression de l'athérosclérose et de l'épaisseur intima média.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 39, doi. 10.2165/00003495-200059992-00005
- Publication type:
- Article
Works matching IS 00126667 AND DT 2000 AND VI 59 AND IP 1
Results: 21
1
2
Les inhibiteurs calciques dans les affections cardiovasculaires.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 25, doi. 10.2165/00003495-200059992-00004
- Publication type:
- Article
3
Tolérance gastro-intestinale des anti-inflammatoires non-stéroïdiens.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 17, doi. 10.2165/00003495-200059991-00003
- By:
- Publication type:
- Article
4
L'amlodipine face aux mécanismes de l'hypertrophie vasculaire.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 1
- By:
- Publication type:
- Article
5
Ganirelix: A Viewpoint by Victor Y. Fujimoto.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 112
- By:
- Publication type:
- Article
6
Ganirelix: A Viewpoint by Thomas Strowitzki.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 112
- By:
- Publication type:
- Article
7
Interactions biophysiques membranaires de l’amlodipine et propriétés antioxydantes.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 9, doi. 10.2165/00003495-200059992-00002
- By:
- Publication type:
- Article
8
Utilisation des inhibiteurs calciques dans le traitement de l'insuffisance cardiaque.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 17, doi. 10.2165/00003495-200059992-00003
- By:
- Publication type:
- Article
9
Affections rhumatismales.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 1, doi. 10.2165/00003495-200059991-00001
- By:
- Publication type:
- Article
10
Les anti-inflammatoires non-stéroïdiens dans la prise en charge des affections rhumatismales.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 11, doi. 10.2165/00003495-200059991-00002
- By:
- Publication type:
- Article
11
Modalités d'utilisation de la nabumétone et expérience clinique.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 35
- By:
- Publication type:
- Article
12
Propriétés et spécificités de la nabumétone.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 25
- By:
- Publication type:
- Article
13
Ganirelix.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 107, doi. 10.2165/00003495-200059010-00007
- By:
- Publication type:
- Article
14
Pituitary Disorders: Drug Treatment Options.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 93, doi. 10.2165/00003495-200059010-00006
- By:
- Publication type:
- Article
15
An Evaluation of Pharmacological Strategies for the Prevention and Treatment of Acute Renal Failure.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 79, doi. 10.2165/00003495-200059010-00005
- By:
- Publication type:
- Article
16
Moxifloxacin: A Review of its Clinical Potential in the Management of Community-Acquired Respiratory Tract Infections.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 115
- By:
- Publication type:
- Article
17
Advances in Non-Nicotine Pharmacotherapy for Smoking Cessation.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 17, doi. 10.2165/00003495-200059010-00003
- By:
- Publication type:
- Article
18
Oxazolidinones: A Review.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 7
- By:
- Publication type:
- Article
19
HMG-CoA Reductase Inhibitors in the Prevention of Stroke.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 1, doi. 10.2165/00003495-200059010-00001
- By:
- Publication type:
- Article
20
Felodipine/Metoprolol: A Review of the Fixed Dose Controlled Release Formulation in the Management of Essential Hypertension.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 141
- By:
- Publication type:
- Article
21
Pharmacology of AMPA/Kainate Receptor Ligands and Their Therapeutic Potential in Neurological and Psychiatric Disorders.
- Published in:
- Drugs, 2000, v. 59, n. 1, p. 33, doi. 10.2165/00003495-200059010-00004
- By:
- Publication type:
- Article